Beaver Run Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Antibodies as Drugs: New Horizons in the Therapeutic Use of Engineered Antibodies (D2)

Scientific Organizers: Christian Klein, Mark S. Cragg and Germaine Fuh


April 7—11, 2019

Beaver Run Resort, Breckenridge, Colorado, USA


Sponsored by AbbVie Inc., Bioverativ Therapeutics, ImmunoGen, Inc., Incyte Corporation, MorphoSys AG, Roche and Valerion Therapeutics


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Dec 11, 2018 [details]
Discounted Abstract Deadline: Dec 11, 2018 [details]
Abstract Deadline: Jan 9, 2019 [details]
Discounted Registration Deadline: Feb 6, 2019 [details]


Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-D2 "Antibodies as Drugs: New Horizons in the Therapeutic Use of Engineered Antibodies" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On December 11, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After December 11, 2018 until January 9, 2019 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
December 11, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On February 6, 2019 845.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After February 6, 2019 1045.00 USD
Discounted STUDENT Registration
More details
Before and On February 6, 2019 620.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After February 6, 2019 820.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.

Apply for a Scholarship



Discounted Abstract Deadline: December 11, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is January 9, 2019)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: December 11, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: January 9, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is December 11, 2018)

Discounted Registration Deadline: February 6, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 845.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 620.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1045.00 USD*
Student Registration Fee: 820.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, April 7 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, April 11 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, April 12 in order to fully experience the meeting.

SUNDAY, APRIL 7

16:00—20:00
Arrival and Registration

Colorado Ballroom Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Colorado Ballroom Foyer

MONDAY, APRIL 8

07:00—08:00
Breakfast

Summit Gallery
08:00—09:30
Welcome and Keynote Session
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
George D. Yancopoulos, Regeneron Pharmaceuticals, Inc., USA
Target Identification and Developing Antibodies for Clinical Application

Jennifer R. Cochran, Stanford University, USA
Emerging Strategies for Developing Next-Generation Protein Therapeutics

Coffee Break

09:50—11:45
Mechanisms of Action for Depleting Antibodies
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
Mark S. Cragg, University of Southampton, UK
Targeting B Cells with Antibodies: From Oncology to Autoimmunity

Falk Nimmerjahn, Universitätsklinikum Erlangen, Germany
Optimal Formats for Target Cell Deletion

Short Talk(s) Chosen from Abstracts

11:45—17:00
On Own for Lunch

11:45—13:00
Poster Setup

Breckenridge Ballroom
13:00—22:00
Poster Viewing

Breckenridge Ballroom
14:30—16:30
Workshop 1: Engineering (Bispecific) Antibodies

Colorado Ballroom
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Colorado Ballroom Foyer
17:00—19:00
Antibody Engineering
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
Janine Schuurman, Genmab B.V., Netherlands
Engineering Non-Classical Antibody Formats

Feng Wang, Institute of Biophysics, China
Engineering Antagonistic and Agonistic Antibodies

Germaine Fuh, 23andMe, USA
Engineering Antibody Specificity and Stability Using Deep Sequencing

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Breckenridge Ballroom
19:30—22:00
Poster Session 1

Breckenridge Ballroom

TUESDAY, APRIL 9

07:00—08:00
Breakfast

Summit Gallery
08:00—11:00
Bispecific and Engineered Antibodies for Cancer Immunotherapy
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
Nai-Kong V. Cheung, Memorial Sloan-Kettering Cancer Center, USA
Cancer Immunotherapy with Bispecific Antibodies

Christian Klein, Roche, Switzerland
Engineering Bispecific Antibodies for Combination Cancer Immunotherapy

Coffee Break

Marie H. Kosco-Vilbois, NovImmune SA, Switzerland
Bispecific CD47 Antibodies for Treatment of Cancer and Autoimmunity

John R. Desjarlais, Xencor, USA
Bispecific Antibodies for T Cell Recruitment and T Cell Activation

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Breckenridge Ballroom
13:00—22:00
Poster Viewing

Breckenridge Ballroom
16:30—17:00
Coffee Available

Colorado Ballroom Foyer
17:00—19:00
Antibodies for Infectious Diseases
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
David D. Ho, Aaron Diamond AIDS Research Center, USA
Novel Antibodies for HIV Therapy and Prevention

JoAnn A. Suzich, MedImmune, USA
Antibodies for Prevention and Treatment of Viral Infections

Kartik Chandran, Albert Einstein College of Medicine, USA
Catching Viruses in Endosome Using Bispecific Antibodies

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Breckenridge Ballroom
19:30—22:00
Poster Session 2

Breckenridge Ballroom

WEDNESDAY, APRIL 10

07:00—08:00
Breakfast

Summit Gallery
08:00—11:00
Next Generation Antibody Drug Conjugates
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
Ronit Mazor, Medimmune, Inc., USA
Progress with Antibody Toxin Fusion Proteins and Overcoming Immunogenicity

Richard J. Gregory, ImmunoGen, Inc., USA
Optimizing the Activity of Antibody Drug Conjugates

Coffee Break

John M. Lambert†, ImmunoGen, Inc., USA
The Promise of ADCs: A Simple Concept, Difficult to Execute! Where Are We Now?

W. Michael Kavanaugh, CytomX Therapeutics, Inc., USA
Probody Therapeutics: Antibody Pro-drugs Designed for Safer and More Effective Cancer Therapies

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Breckenridge Ballroom
13:00—22:00
Poster Viewing

Breckenridge Ballroom
16:30—17:00
Coffee Available

Colorado Ballroom Foyer
17:00—19:00
Delivering Antibodies into the Brain
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
Joy Yu Zuchero, Denali Therapeutics Inc, USA
Novel Approaches for Delivery of Antibodies into the Brain

Per-Ola Freskgård, F. Hoffmann-La Roche, Switzerland
Crossing the Blood Brain Barrier with Antibodies to Access Brain Targets

Allan Jensen, Lundbeck, Denmark
Antibody based Therapies for Neurodegenerative Diseases

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Breckenridge Ballroom
19:30—22:00
Poster Session 3

Breckenridge Ballroom

THURSDAY, APRIL 11

07:00—08:00
Breakfast

Summit Gallery
08:00—11:00
Bispecific Antibodies and Antibody Like Molecules
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
Christoph Rader, The Scripps Research Institute, USA
Chemically Programmed Antibodies

James A. Ernst, Genentech, Inc., USA
A Novel Bispecific Antibody Mimetic of FGF21 for the Treatment of Metabolic Disease and NASH

Coffee Break

Andreas G. Plückthun, University of Zürich, Switzerland
Engineering DARPins for Delivery into Cells

Yvonne Y. Chen, University of California, Los Angeles, USA
Engineering Next-Generation Chimeric Antigen Receptors

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

14:30—16:30
Workshop 2: Antibodies for Immunological Applications

Colorado Ballroom
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Colorado Ballroom Foyer
17:00—18:45
Beyond Checkpoint Blockade: Novel Approaches for Immunotherapy
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
Mikael C. I. Karlsson, Karolinska Institutet, Sweden
Anti-Marco Antibodies in Tumor Immunotherapy

Sean Hua Lim, University of Southampton, UK
Targeting CD27

Elaine M. Paul, GlaxoSmithKline, USA
GSK 3359609 a Non-Depleting IgG4 Anti-ICOS Antibody

Short Talk Chosen from Abstracts

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 03/07/2019

Colorado Ballroom
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Breckenridge Ballroom
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Breckenridge Ballroom

FRIDAY, APRIL 12

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

AbbVie Inc. Bioverativ Therapeutics
ImmunoGen, Inc. Incyte Corporation
MorphoSys AG Roche
Valerion Therapeutics
 

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



ImmunoGen, Inc.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676